References
- Sauder DN. Immunomodulatory and pharmacologic properties of imiquimod. J Am Acad Dermatol 2000;43:6–11
- Turriziani M, Giuliani A, Bulgarini B, De Vecchis L. Role of levamisole as immunomodulant in mouse lymphoma model. Immunopharm Immunot 1991;13:425–445
- Li S, Parish EJ, Rodriguez-Valenzuela C. Synthesis of new steroid al isoxazoles: inhibitors of estrogen synthase. Bioorgan Med Chem 1998;6:1525–1529
- Eddington N, Cox D, Roberts R, et al. Synthesis and anticonvulsant activity of enaminones. 4. Investigations on isoxazole derivatives. Eur J Med Chem 2002;37:635–648
- Mazzei M, Sottofattori E, Dondero R, et al. N,N-Dialkylaminosubstitued chromones and isoxazoles as potential anti-inflammatory agents. Il Farmaco 1999;54:452–460
- Srivastava S, Bajpai KL, Batra S, et al. In search of new chemical antities with spermicidal and anti-HIV activities. Bioorg Med Chem 1999;7:2607–2613
- Bukhari S, Jantan I, Wai LK, et al. Synthesis and effects of pyrazolines and isoxazoles on the phagocytic chemotaxis and release of reactive oxygen species by zymosan stimulated human neutrophils. Med Chem 2013;9:1091–1098
- Ryng S, Zimecki M, Sonnenberg Z, Mokrosz MJ. Immunomodulating action and structure-activity relationships of substituted phenylamides of 5-amino-3-methylisoxazole-4-carboxylic acid. Arch Pharm 1999;332:158–162
- Bartlett RR, Dimitrijevic M, Mattar T, et al. Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection. Agents Actions 1991;32:10–21
- Mączyński M, Zimecki M, Ryng S. A new class of isoxazole derivatives: the M 1-9 series of compounds with immunotropic activity. Acta Pol Pharm Drug Res 2008;65:241–244
- Mączyński M, Zimecki M, Taraszkiewicz M, Ryng S. Synthesis, immunological activity and computational study of 5-amino-3-methyl-4-isoxazolecarboxylic acid semicarbazides and thiosemicarbazides. Acta Pol Pharm Drug Res 2008;65:543–549
- Drynda A, Mączyński M, Ryng S, Obmińska-Mrukowicz B. In vitro immunomodulatory effects of 5-amino-3-methyl-4-isoxazolecarboxylic acid hydrazide on the cellular immune response. Immunopharm Immunot 2014;36:150–157
- Mishell RJ, Dutton RW. Immunization of dissociated spleen cell cultures from normal mice. J Exp Med 1967;126:423–442
- Hudson L, Hay FC. Practical immunology. Oxford, London, Edinburgh, Boston, Melbourne: Blackwell Scientific Publications; 1980;247–250
- O'Garra A, Arai N. The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends Cell Biol 2000;10:542–550
- Tang Q, Bluestone JA. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat Immunol 2008;9:239–244
- Kim JM, Rasmussen JP, Rudensky AY. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 2007;8:191–197
- Zhou X, Bailey-Bucktrout S, Jeker L, Bluestone J. Plasticity of CD4+FoxP3+ cells. Curr Opin Immunol 2009;21:281–285
- Pasare C, Medzhitov R. Tool pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 2003;299:1033–1036
- Lanzavecchia A. Antigen-specific interaction between T and B cells. Nature 1985;314:537–539
- Andersson J, Schreier MH, Melchers F. T-cell dependent B-cell stimulation is H-2 restricted and antigen dependent only at the resting B-cell level. Proc Natl Acad Sci USA 1980;77:1612–1616
- Spriggs MK, Armitage RJ, Strockbine L, et al. Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J Exp Med 1992;176:1543–1550
- Foy TM, Laman JD, Ledbetter JA, et al. gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J Exp Med 1994;180:157–163
- Coffman RL, Seymour BW, Lebman DA, et al. The role of helper T cell products in mouse B cell proliferation and isotype regulation. Immunol Rev 1988;102:5–28
- Mandler R, Chu CC, Paul W, et al. Interleukin 5 induces S mu-S gamma 1 DNA rearrangement in B cells activated with dextran-anti-IgD antibodies and interleukin 4: a three component model for Ig class switching. J Exp Med 1993;178:1577–1586
- Gupta RK, Griffin P, Chang AC, et al. The role of adjuvants and delivery systems in modulation of immune response to vaccines. Adv Exp Med Biol 1996;397:105–113
- Gupta RK, Relyveld EH, Lindblad EB, et al. Adjuvants – a balance between toxicity and adjuvanticity. Vaccine 1993;11:293–306